PROVECTUS BIOPHARMACEUTICALS, INC.·4

Jul 2, 12:39 PM ET

Pershing Edward 4

4 · PROVECTUS BIOPHARMACEUTICALS, INC. · Filed Jul 2, 2026

Research Summary

AI-generated summary of this filing

Updated

PVCT 10% Owner Pershing Edward Receives Award (Convertible Preferred)

What Happened

  • Pershing Edward (reported as a 10% owner) is listed as receiving 45,860 derivative shares on 2026-06-30. The filing shows a grant/award (code A) at $0.00 per share, reported as Series D‑1 Convertible Preferred Stock. On paper this represents the right to convert into up to 458,600 common shares (conversion ratio 1 preferred → 10 common).
  • The filing value is $0 and the reported instrument is a convertible preferred security rather than an immediate cash purchase or sale. A footnote also states the Series D‑1 will automatically convert into common stock on December 31, 2028, unless converted earlier.

Key Details

  • Transaction date: 2026-06-30; Form 4 filed: 2026-07-02.
  • Reported amount: 45,860 derivative shares at $0.00 (Series D‑1 Convertible Preferred).
  • Conversion: each Series D‑1 preferred is convertible into 10 common shares (so 45,860 preferred → 458,600 common if converted).
  • Automatic conversion date: December 31, 2028 (unless earlier conversion per terms).
  • Footnote correction: the filing includes an adjustment to correct a prior Form 4 typographical error — the filer says this adjustment does not reflect a new transaction by the reporting person.
  • Shares owned after transaction: not specified in this filing.
  • Timeliness: no late‑filing indicator shown in the filing.

Context

  • This is a derivative award (convertible preferred), not an open‑market purchase or sale; such awards often arise from financing, settlement, or compensation arrangements and do not necessarily signal immediate buying/selling intent.
  • As a 10% owner (institutional/major holder), this filing reflects ownership and convertible rights rather than routine executive trading. The footnote correction suggests the report may be an administrative fix rather than a new economic transfer.

Insider Transaction Report

Form 4
Period: 2026-06-30
Pershing Edward
DirectorCEO10% Owner
Transactions
  • Award

    Series D-1 Convertible Preferred Stock

    [F1][F2][F3]
    2026-06-30+45,8602,866,761 total
    From: 2026-06-30Common Stock (458,600 underlying)
Footnotes (3)
  • [F1]Each share of Series D-1 Preferred Stock is convertible into 10 shares of the Issuer's common stock, par value $0.001 per share ("Common Stock").
  • [F2]The Series D-1 Convertible Preferred Stock will automatically convert into Common Stock on December 31, 2028, unless earlier converted into Common Stock in accordance with the terms of the Certificate of Designation for the Series D-1 Convertible Preferred Stock.
  • [F3]The amount reported reflects an adjustment to correct a typographical error in a previously filed Form 4. This adjustment does not reflect a transaction by the Reporting Person.
Signature
/s/ Ed Pershing|2026-07-02

Documents

1 file
  • 4
    ownership.xmlPrimary

    4